title: CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses.
abstract: The conventional C-strain vaccine induces early protection against classical swine fever (CSF), but infected animals cannot be distinguished from vaccinated animals. The CP7_E2alf marker vaccine, a pestivirus chimera, could be a suitable substitute for C-strain vaccine to control CSF outbreaks. In this study, single oral applications of CP7_E2alf and C-strain vaccines were compared for their efficacy to induce protection against a CSF virus (CSFV) challenge with the moderately virulent Bas-Rhin isolate, in pigs as early as two days post-immunization. This work emphasizes the powerful potential of CP7_E2alf vaccine administered orally by a rapid onset of partial protection similar to that induced by the C-strain vaccine. Furthermore, our results revealed that both vaccinations attenuated the effects induced by CSFV on production of the pig major acute phase protein (PigMAP), IFN-α, IL-12, IL-10, and TGF-β1 cytokines. By this interference, several cytokines that may play a role in the pathogeny induced by moderately virulent CSFV strains were revealed. New hypotheses concerning the role of each of these cytokines in CSFV pathogeny are discussed. Our results also show that oral vaccination with either vaccine (CP7_E2alf or C-strain) enhanced CSFV-specific IgG2 production, compared to infection alone. Interestingly, despite the similar antibody profiles displayed by both vaccines post-challenge, the production of CSFV-specific IgG1 and neutralizing antibodies without challenge was lower with CP7_E2alf vaccination than with C-strain vaccination, suggesting a slight difference in the balance of adaptive immune responses between these vaccines.
authors: Anses, Ploufragan/Plouzané laboratory, Swine Virology and Immunology Unit, BP53, 22440, Ploufragan, France. marie-frederique.lepotier@anses.fr.
authors: Patricia
authors: P
authors: Renson
authors: Mireille
authors: M
authors: Le Dimna
authors: André
authors: A
authors: Keranflech
authors: Roland
authors: R
authors: Cariolet
authors: Frank
authors: F
authors: Koenen
authors: Marie-Frédérique
authors: MF
authors: Le Potier
mesh_terms: D056704:Adaptive Immunity; D000284:Administration, Oral; D000818:Animals; D057134:Antibodies, Neutralizing / Q000097:blood; D000914:Antibodies, Viral / Q000097:blood*; D006691:Classical Swine Fever / Q000276:immunology* / Q000517:prevention & control / Q000821:virology; D006692:Classical Swine Fever Virus / Q000276:immunology*; D016207:Cytokines / Q000276:immunology*; D013047:Specific Pathogen-Free Organisms; D013552:Swine; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology / Q000494:pharmacology; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology* / Q000494:pharmacology
chemical_list: D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D016207:Cytokines; D014613:Vaccines, Attenuated; D014765:Viral Vaccines
references: Vet Res. 2004 Mar-Apr;35(2):163-87
references: 15099494
references: Vet Res. 2010 Jan-Feb;41(1):7
references: 19793538
references: Vet Microbiol. 2001 Oct 1;82(4):301-10
references: 11506924
references: J Vet Med B Infect Dis Vet Public Health. 2003 Jun;50(5):214-20
references: 12864895
references: Vet Pathol. 2005 Jul;42(4):477-88
references: 16006607
references: Vaccine. 2012 Apr 5;30(17):2742-8
references: 22366027
references: Vaccine. 2009 Nov 5;27(47):6522-9
references: 19732859
references: Vet Res. 2007 Sep-Oct;38(5):741-53
references: 17637332
references: Virus Res. 2010 Mar;148(1-2):60-70
references: 20034523
references: Vaccine. 2010 Nov 23;28(50):7907-14
references: 20933567
references: Vet Microbiol. 2009 Mar 30;135(3-4):196-204
references: 18986777
references: J Virol Methods. 2009 Jun;158(1-2):114-22
references: 19428579
references: Vet Microbiol. 2008 Nov 25;132(1-2):29-38
references: 18534790
references: Am J Vet Res. 2007 Jul;68(7):772-7
references: 17605613
references: Vet Microbiol. 2010 Apr 21;142(1-2):51-8
references: 19896784
references: Vaccine. 2007 Apr 30;25(17):3391-9
references: 17257713
references: PLoS One. 2012;7(1):e29310
references: 22235283
references: Virology. 2004 Apr 25;322(1):143-57
references: 15063124
references: Vaccine. 2011 May 17;29(22):3888-94
references: 21443961
references: Vet Res. 2008 Jan-Feb;39(1):7
references: 18073094
references: J Immunol. 2008 May 1;180(9):5771-7
references: 18424693
references: Vet Microbiol. 2011 Dec 15;153(3-4):373-6
references: 21684092
references: Vet Immunol Immunopathol. 2001 Dec;83(3-4):177-89
references: 11730928
references: Vet Immunol Immunopathol. 2011 Aug 15;142(3-4):243-51
references: 21684019
references: Vet Res. 2005 Jul-Aug;36(4):571-87
references: 15955282
references: FASEB J. 1987 Dec;1(6):456-61
references: 3315808
references: Vaccine. 2012 Apr 19;30(19):2928-36
references: 22406108
references: Trends Microbiol. 2007 Apr;15(4):143-6
references: 17336072
references: J Comp Pathol. 2002 Nov;127(4):239-48
references: 12443731
references: J Interferon Cytokine Res. 2006 Apr;26(4):248-55
references: 16704301
references: J Immunol Methods. 2005 Nov 30;306(1-2):16-27
references: 16223507
references: Vet Immunol Immunopathol. 2004 Dec 8;102(3):199-216
references: 15507306
references: J Immunol. 1998 Oct 1;161(7):3400-7
references: 9759857
references: Vaccine. 2007 Jul 26;25(30):5665-70
references: 17239502
references: PLoS One. 2010 Oct 15;5(10):e13408
references: 20976218
references: Vet Immunol Immunopathol. 2005 Jul 15;106(3-4):197-208
references: 15963818
references: J Comp Pathol. 2001 Aug-Oct;125(2-3):98-109
references: 11578124
references: Vet Microbiol. 2010 Apr 21;142(1-2):59-68
references: 19857935
references: J Leukoc Biol. 2004 Jul;76(1):15-24
references: 14966194
references: Vet Microbiol. 2010 Apr 21;142(1-2):99-107
references: 19854007